ANEW Medical Price to Free Cash Flow Ratio 2023-2024 | KLTO

Historical price to free cash flow ratio values for ANEW Medical (KLTO) since 2023. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
ANEW Medical Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-09-18 0.89 inf
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.015B $0.000B
ANEW MEDICAL INC. specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The company's focus on central nervous systems diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease, dementia symptoms and neuromuscular diseases. ANEW MEDICAL INC., formerly known as REDWOODS ACQ, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Plum Acquisition I (VEEA) United States $0.138B 0.00
Pono Capital Two (SBC) United States $0.000B 0.00
Edgio (EGIOQ) United States $0.000B 0.00